United Orthopedic Corporation · TPEX:4129
United Orthopedic — Q3 2024 Earnings Presentation
17 slides from United Orthopedic's earnings presentation, Nov 19, 2024
Slide 1: United Orthopedic Corporation 2024 Investor Conference
United Orthopedic Corporation 2024 Investor Conference November 19, 2024
Slide 2: Safe Harbor Notice
Safe Harbor Notice Except for historical information set forth herein, this presentation contains certain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from what may be expressed or implied by such statements. Investors sh
Slide 3: Agenda
Agenda Performance in the third-quarter of 2024 Performance in the first three quarters of 2024 Business Update Q&A 3
Slide 4: Revenue in the third-quarter of 2024
Revenue in the third-quarter of 2024 NT$ 1,131 million 2023 2024 (NT$ millions) YoY% Q3 Q3 Revenue 934.4 1,130.6 21% APAC 445.3 521.3 17% EMEA 259.4 322.8 24% America 229.7 286.5 25% 4
Slide 5: Revenue by Regions
Revenue by Regions 2023 Q3 2024 Q3 NT$ 934 M NT$ 1,131 M America 24% America 25% APAC APAC 48% 46% EMEA 28% EMEA 29% 5
Slide 6: Performance in the third-quarter of 2024
Performance in the third-quarter of 2024 (NT$ thousands) 2023 Q3 2024 Q3 DIFF % Revenue 934,365 1,130,636 196,271 +21% Operating P/L 171,186 159,468 (11,718) - 7% Non-OP P/L (1,506) 18,883 20,388 +1,354% Net Profit 112,682 138,403 25,721 +23% % 12% 12% EPS 1.30 1.44 0.14 +11% 6
Slide 7: Revenue in the first 3 quarters of 2024
Revenue in the first 3 quarters of 2024 NT$ 3,337 million (History high) 2023 2024 (NT$ millions) YoY% Q1~Q3 Q1~Q3 Revenue 2,795.8 3,337.2 19% APAC 1,328.6 1,523.1 15% EMEA 888.9 1,068.2 20% America 578.3 745.9 29% 7
Slide 8: Revenue by Regions
Revenue by Regions 2023 Q1~Q3 2024 Q1~Q3 NT$ 2,796 M NT$ 3,337 M America 21% America 22% APAC APAC EMEA 47% 46% 32% EMEA 32% 8
Slide 9: Performance in the first 3 quarters of 2024
Performance in the first 3 quarters of 2024 (NT$ thousands) 2023 Q1~Q3 2024 Q1~Q3 DIFF % Revenue 2,795,770 3,337,208 541,438 +19% Operating P/L 387,510 441,401 53,891 +14% Non-OP P/L (25,638) 11,484 37,122 +145% Net Profit 264,423 334,408 69,985 +26% % 9% 10% 1% EPS 3.14 3.48 0.34 +11% 9
Slide 10: Operating Results by Quarter
Operating Results by Quarter Revenue Trend Chart Financial Ratios GM% OP EXP% 1,200 (NT$ millions) 1,134 1,141 1,131 1,066 10% 10% 9% 79% 8% 78% 78% 78% 78% 925 928 933 934 77% 77% 90% 92% 90% 91% 75% 9% 9% 11% 11% 75% 74% 740 744 759 74% 91% 91% 89% 89% 10% 11% 12% 600 90% 89% 88% 66% 66% 66% 66% 6
Slide 11: Overview of Global Deployments
Overview of Global Deployments 11
Slide 12: Performance in the APAC Market
Performance in the APAC Market Third-quarter revenue First 3 quarters revenue (NT$ millions) (NT$ millions) +17% 521 450 1,600 +15% 1,523 +10% 445 404 1,329 +16% 225 1,141 800 0 2022 Q3 2023 Q3 2024 Q3 0 2022 Q1~Q3 2023 Q1~Q3 2024 Q1~Q3 12
Slide 13: Performance in the EMEA Market
Performance in the EMEA Market Third-quarter revenue First 3 quarters revenue (NT$ millions) (NT$ millions) +24% 1,100 1,068 323 +20% 889 +34% 259 +40% 194 636 550 2022 Q3 2023 Q3 2024 Q3 0 2022 Q1~Q3 2023 Q1~Q3 2024 Q1~Q3 13
Slide 14: Performance in the American Market
Performance in the American Market Third-quarter revenue First 3 quarters revenue (NT$ millions) 300 (NT$ millions) +25% 287 800 746 +29% +42% 230 150 +24% 578 161 467 400 0 2022 Q3 2023 Q3 2024 Q3 0 2022 Q1~Q3 2023 Q1~Q3 2024 Q1~Q3 14
Slide 15: Revenue for October 2024
Revenue for October 2024 NT$ 460 million (YoY +13% ; Monthly record high) (NT$ millions) Oct. 2023 Oct. 2024 YoY% Revenue 406.9 460.3 13% APAC 170.5 180.9 6% EMEA 136.9 150.0 10% America 99.4 129.4 30% 15
Slide 16: Revenue for January to October 2024
Revenue for January to October 2024 NT$ 3,798 million (YoY +19% ; continued to set new all-time highs) 2023 2024 (NT$ millions) YoY% Jan. ~ Oct. Jan. ~ Oct. Revenue 3,202.6 3,797.5 19% APAC 1,499.1 1,704.0 14% EMEA 1,025.8 1,218.2 19% America 677.7 875.3 29% 16
Slide 17: Thank you for listening
Thank you for listening Each Step We Care